PubMed Health⌕ Search

Biomedical subjects

D Utley

Publications and source records attributed to D Utley.

13 recordsLinked to original sources

Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease.

BACKGROUND AND AIMS: Radiofrequency energy (RFe) treatment to the lower oesophageal sphincter (LOS) and gastric cardia is a new luminally delivered therapy proposed as an alternative treatment for gastro-oesophageal reflux disease (GORD). However, it is unclear how RFe achieves its antireflux effect. This study investigated the effects of RFe on mechanisms of spontaneous reflux in patients with GORD. METHODS: Twenty patients with GORD underwent endoscopy, symptom evaluation, and combined postprandial oesophageal manometry and pH monitoring before and six months after RFe, and 24 hour ambulatory pH monitoring before and at six and 12 months after treatment. RESULTS: RFe reduced the rate of postprandial transient LOS relaxations from 6.8 (5.7-8.1) (median (interquartile range) per hour to 5.2 (4.2-5.8) per hour (p<0.01), and increased mean basal LOS pressure from 5.2 (SEM 0.3) mm Hg to 8.0 (SEM 0.4) mm Hg (p<0.01). The number of reflux events was reduced from 10 (2-15.3)/3 hours to 5 (3.5-8.5)/3 hours (p<0.05) and there was an associated significant reduction in acid exposure time from 5.4% (0.4-14.7) to 3.9% (0.4-6.6) (p<0.05). RFe significantly reduced ambulatory oesophageal acid exposure from 10.6% (7.8-13.0) to 6.8% (3.1-9.1) (p<0.01) at six months and 6.3% (4.7-10.9) (p<0.05) at 12 months. All patients required acid suppressant medication for symptom control before RFe. Six months after treatment, 15 patients (75%) were in symptomatic remission and 13 (65%) at 12 months. CONCLUSIONS: RFe has significant effects on LOS function that are associated with improvement in the antireflux barrier. Uncontrolled clinical data also suggest a beneficial effect in the control of reflux symptoms in these patients.

Adult↗

Simultaneous determination of hydroxylamine and cyanide in formulations containing pralidoxime salts by flow injection.

A flow injection method is described for the simultaneous determination of cyanide and hydroxylamine which are known decomposition products of formulations containing pralidoxime salts used in the treatment of anticholinesterase poisoning. By using the diffusion of HCN from the carrier stream followed by amperometric detection, high selectivity and sensitivity and a wide dynamic range can be achieved. Hydroxylamine is determined by its oxidation with iodine to nitrite which can then be determined colorimetrically. The gas diffusion unit effectively acts as a stream splitter for the two analytes allowing their simultaneous determination from a single sample injection. The performance of the system and its applicability to thermally stressed pralidoxime solutions are described.

Autoanalysis↗

Analysis of formulations containing pralidoxime mesylate by liquid chromatography.

An improved liquid chromatography procedure has been devised for the analysis of pralidoxime mesylate (P2S) and its degradation products in solution. An additional degradation product, 2-hydroxyaminoiminomethyl-1-methylpyridinium, has been positively identified and its route of formation and that of another recently identified product, 2-hydroxymethyl-1-methylpyridinium, has been established. Previous problems with the chromatography of 2-formyl-1-methylpyridinium have been resolved and the new method will resolve P2S and eight of its degradation products.

Alcohols↗